Companies: 10,795·Total market cap: $144.5T

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.

KPTINASDAQHealthcare● Active

$8.50

$-0.58(-6.39%)

Market Cap$192635016

P/E Ratio—

52W High$10.99

52W Low$3.65

Avg Volume900K

Open$9.18

Beta0.82

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Karyopharm Therapeutics Inc.（KPTI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KPTI · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-14.84Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$151.1MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding10.9MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Karyopharm Therapeutics Inc. 数据

分析师预测$17 · Buy

股息不分红

营收$146.1M+0.57%

盈利EPS $-17.93-90.54%

财务快照

FY 2025Revenue$146.1M▲ +0.57% YoY

202320242025

FY 2025Net Income-$196.0M▼ 156.52% YoY

202320242025

FY 2025EPS$-17.93▼ 90.54% YoY

202320242025

TTM:Revenue: $151.1MNet Income: -$195.0MEPS: $-14.84View income statement →

分析师评级与目标价

Buy20 位分析师

Strong Buy

0

Buy

14

Hold

4

Sell

2

Strong Sell

0

12-Month Price Target

$12.00Low

$8.50Current

$17.25Avg Target上涨空间 102.94%

$28.00High

合计: 20 · 买入占比: 70.0%

根据过去 3 个月内 20 位华尔街分析师，KPTI 共识评级为 Buy，12 个月平均目标价 $17.25 （较现价 $8.50 上涨空间 102.94%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Karyopharm Therapeutics Inc.

$8.50-6.39%$192.6M #2

Aligos Therapeutics, Inc.

$4.96+1.02%$30.7M #3

Barinthus Biotherapeutics plc

$0.72+10.41%$29.4M #4

CEL-SCI Corporation

$1.38+0.73%$9.5M #5

$9.07-1.63%$36.7M #6

INmune Bio, Inc.

$1.24-1.59%$33.0M

股票表现

1D-6.39%

1W-5.56%

1M-1.62%

3M+0.12%

YTD+15.49%

1Y+101.90%

5Y-94.34%

关于 Karyopharm Therapeutics Inc.

CEORichard A. Paulson

IPO DateNov 6, 2013

Employees279

CountryUS

Websitekaryopharm.com

Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pat…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Karyopharm Therapeutics Inc.（KPTI）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 6, 2013 在 NASDAQ 上市。截至最近交易日，KPTI 股价为 $8.50，市值约为 $192.6M。过去12个月累计回报 +101.90%，年初至今回报 +15.49%。

根据 20 位华尔街分析师，Karyopharm Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $17.25。2025 财年 Karyopharm Therapeutics Inc. 营收 $146.1M，净利润 -$196.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Karyopharm Therapeutics Inc.（KPTI）股价为 $8.50，在 NASDAQ 上市，52周区间为 $3.65 – $10.99。

KPTI 最新股价KPTI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议